Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perlin

Showing results (431-440 of 985) with videos related to

Pageof 99
Sort By:
Physical Review Letters|July 10, 1995
Towards the identification of the dominant donor in GaNPerlin, Suski, Teisseyre, et al.
Cancer Chemotherapy Reports|July 1, 1975
Treatment of malignant melanoma with vinblastine (NSC-49842), procarbazine (NSC-77213), and actinomycin D (NSC-3053)E Perlin, J Engeler, J W Reid, et al.
Urologiia I Nefrologiia|May 1, 1995
[The ultrasonic diagnosis of vesicoureteral reflux]M F Trapeznikova, S B Urenkov, A B Sobolevskiĭ, et al.
Plos One|July 24, 2008
Cheating on the edgeLee Alan Dugatkin, Aaron D Dugatkin, Ronald M Atlas, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignanciesGuillermo Garcia-Effron, Dimitrios P Kontoyiannis, Russell E Lewis, et al.
Journal of Forensic Sciences|September 10, 2009
Upper-bounding the incidence rate of associations between camouflage uniforms and surveillance imagesNorman Adams, Victor Perlin, Mitchell Rohde, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2021
Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?Maria Siopi, David S Perlin, Maiken C Arendrup, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|August 31, 2012
Rapid core measure improvement through a "business case for quality"Jonathan B Perlin, Stephen J Horner, Jane D Englebright, et al.
NAM Perspectives|September 17, 2021
Care Systems COVID-19 Impact Assessment: Lessons Learned and Compelling NeedsJeffrey Balser, Jaewon Ryu, Michelle Hood, et al.
The Journal of Biological Chemistry|December 25, 1989
Defective H(+)-ATPase of hygromycin B-resistant pma1 mutants fromSaccharomyces cerevisiaeD S Perlin, S L Harris, D Seto-Young, et al.
Pageof 99

Showing results (431-440 of 985) with videos related to

Sort By:
Pageof 99
Physical Review Letters|July 10, 1995
Towards the identification of the dominant donor in GaNPerlin, Suski, Teisseyre, et al.
Cancer Chemotherapy Reports|July 1, 1975
Treatment of malignant melanoma with vinblastine (NSC-49842), procarbazine (NSC-77213), and actinomycin D (NSC-3053)E Perlin, J Engeler, J W Reid, et al.
Urologiia I Nefrologiia|May 1, 1995
[The ultrasonic diagnosis of vesicoureteral reflux]M F Trapeznikova, S B Urenkov, A B Sobolevskiĭ, et al.
Plos One|July 24, 2008
Cheating on the edgeLee Alan Dugatkin, Aaron D Dugatkin, Ronald M Atlas, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignanciesGuillermo Garcia-Effron, Dimitrios P Kontoyiannis, Russell E Lewis, et al.
Journal of Forensic Sciences|September 10, 2009
Upper-bounding the incidence rate of associations between camouflage uniforms and surveillance imagesNorman Adams, Victor Perlin, Mitchell Rohde, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2021
Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?Maria Siopi, David S Perlin, Maiken C Arendrup, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|August 31, 2012
Rapid core measure improvement through a "business case for quality"Jonathan B Perlin, Stephen J Horner, Jane D Englebright, et al.
NAM Perspectives|September 17, 2021
Care Systems COVID-19 Impact Assessment: Lessons Learned and Compelling NeedsJeffrey Balser, Jaewon Ryu, Michelle Hood, et al.
The Journal of Biological Chemistry|December 25, 1989
Defective H(+)-ATPase of hygromycin B-resistant pma1 mutants fromSaccharomyces cerevisiaeD S Perlin, S L Harris, D Seto-Young, et al.
Pageof 99